iTeos Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
46.75
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.10
|
0.03
|
-0.07
|
-70.00%
|
|
2022-06-30
|
1.20
|
0.15
|
-1.05
|
-87.50%
|
|
2022-03-31
|
0.80
|
1.82
|
1.02
|
127.50%
|
|
2021-12-31
|
1.28
|
4.89
|
3.61
|
282.03%
|
|
2021-09-30
|
4.95
|
1.86
|
-3.09
|
-62.42%
|
|
2021-06-30
|
-0.41
|
-0.75
|
-0.34
|
-82.93%
|
|
2021-03-31
|
-0.48
|
-0.39
|
0.09
|
18.75%
|
|
2020-12-31
|
-0.42
|
-0.43
|
-0.01
|
-2.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
2.00
|
|
2021-12-31
|
5.61
|
|
2020-12-31
|
-30.82
|